Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Paramaxâ„¢ Moves Closer To FDA Approval

May 19, 2011 By Bio-Medicine.Org

SALT LAKE CITY, May 19, 2011 /PRNewswire/ — Paradigm Medical
Industries, Inc. (OTC.PK: PDMI) announced today that it had
received notification from its Italian partner, Costruzione
Strumenti Oftalmici (CSO), which manufactures the Paramax™,
that it has provided 26 pages and 24 attachments to the U.S. Food
and Drug Administration (FDA) in order to obtain 510(k) approval
for the Paramax™. This supportive information was submitted
to the FDA for review on Monday, May 16, 2011. The Paramax™
is the next generation of standard ocular eletrophysiology utilized
for early glaucoma detection. Paradigm will begin marketing and
selling the Paramax™ in the United States upon receipt of the
510(k) approval.

“Paradigm is confident that CSO has provided the necessary
additional information to the FDA to allow it to move forward with
its decision to approve this valuable early glaucoma diagnostic
device for sale within the United States within a reasonable amount
of time,” said Stephen L. Davis, Paradigm President and Chief
Executive Officer.

“The Paramax™ represents one of the most reliable and
durable early glaucoma diagnostic devices available in the U.S.
market. It will also provide the earliest diagnosis of glaucoma
available, potentially saving the vision for many who would have
otherwise lost it,” he added.

Sales for Paradigm’s other glaucoma detecting device, the Blood
Flow Analyzer™, have picked up in the United States as an
increased number of physicians are realizing the dependable
information derived from a 15 second test from the ocular blood
flow device can lead to earlier medical intervention, thereby
reducing the risk of further glaucoma-related vision loss.

“The anticipated pairing of the Paramax™ and the
time-tested Blood Flow Analyzer™ will offer the most current
and dynamic combination of tools available to physicians for the
early detection and treatment of glaucoma,” continued Mr.

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech